Patent Assignment
Reel/Frame 015478/0430
Security Interest
Recorded: 2003-10-27
Received: 2004-06-23
Pages: 20
Assignor
HUMANETICS CORPORATION
Executed: 2003-09-11
Assignee
DAVID DENT, AS COLLATERIAL AGENT
6712 ARROWHEAD PASS, EDINA, MN, 55439, UNITED STATES
Covered Properties
(10)
Treatment of Chronic Fatigue Syndrome and Fibromyalgia Syndrome
Application:
10/433,043 →
Use of DELTA5-Androstene-3BETA-Ol-7,17-Dione in the Treatment of Lupus Erythematosus
Application:
10/431,960 →
Method of Modulating the Basal Metabolic Rate of a Dieting Mammal by Administration of a Metabolic Modulating Agent to the Dieting Mammal
Application:
10/340,980 →
Method of achieving accelerated weight loss by administration of a weight loss accelerating agent to a dieting mammal
Application:
60/439,753 →
Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal
Application:
60/439,816 →
Combination of Pinitol and Creatine to Enhance Uptake and Retention of Creatine
Application:
10/240,611 →
Treatment of Menorrhagia, Hypermenorrhea, Dysmenorrhea and Menstrual Migraines by the Administration of an Antibacterial Milk Product
Application:
09/683,070 →
Stimulating Transport of Glucose into Animal Tissue by the Administration of Pinitol
Application:
09/857,245 →
Treatment of Dermatitis by the Topical Application of DELTA5-Androstene-3BETA-Ol-7,17 Dione and Metabolizable Precursors Thereof
Application:
09/805,024 →
Method for Diminishing Wrinkles and Fine Lines of the Skin by the Topical Application of DELTA5-Androstene-3BETA-Ol-7, 17 Dione and Metabolizable Precursors Thereof
Application:
09/799,295 →